AU Patent

AU2016250470A1 — The use of solid carrier particles to improve the processability of a pharmaceutical agent

Assigned to Gilead Sciences Inc · Expires 2016-11-17 · 9y expired

What this patent protects

H:\rec\Intrwovn\NRPortbl\DCC\REC\l1788217_ .docx-24/10/2016 The invention provides a composition comprising, a compound of formula (I) or a pharmaceutically acceptable salt thereof and a plurality of solid carrier particles, as well as methods for using the composition to inhibit…

USPTO Abstract

H:\rec\Intrwovn\NRPortbl\DCC\REC\l1788217_ .docx-24/10/2016 The invention provides a composition comprising, a compound of formula (I) or a pharmaceutically acceptable salt thereof and a plurality of solid carrier particles, as well as methods for using the composition to inhibit the activity of cytochrome P-450.

Drugs covered by this patent

Patent Metadata

Patent number
AU2016250470A1
Jurisdiction
AU
Classification
—
Expires
2016-11-17
Drug substance claim
No
Drug product claim
No
Assignee
Gilead Sciences Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.